Venture Partner
BioGeneration VenturesCheck size: BGV does not publish a standard current startup check-size range on its official site.
The official roster identifies Rob de Ree as Venture Partner. This profile applies BioGeneration Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Lead early investments and help shape European biotechnology companies addressing serious unmet medical needs.
At firm level, BioGeneration Ventures is aligned with lead early investments and help shape European biotechnology companies addressing serious unmet medical needs. This is firm-level guidance, not an invented personal preference.
No personal pass list is public. Opportunities outside BioGeneration Ventures's stated stages, sectors, geography or team criteria should be treated as lower fit rather than a confirmed personal rejection rule.
Lead with founder-market fit, the specific problem, differentiated product or technology, evidence of demand, market size, round stage and why the opportunity matches BioGeneration Ventures's published focus. Address the role of Venture Partner without assuming individual check authority.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Rob de Ree is currently Venture Partner at BioGeneration Ventures, as listed on the firm's official roster. Where the roster does not publish a longer biography, this profile avoids inferring prior employers, education, deals or decision authority.